Furthermore, several very well recognized adverse prognostic markers, which include U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, missing their destructive outcome in individuals taken care of with VO. The only real variable that remained predictive of a shorter progression-no cost survival On t